Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
15.7M
-
Shares change
-
+2.11M
-
Total reported value, excl. options
-
$584M
-
Value change
-
+$84.8M
-
Number of buys
-
47
-
Number of sells
-
-26
-
Price
-
$37.38
Significant Holders of Biohaven Pharmactl Hldg Co L - COM (BHVN) as of Q3 2017
85 filings reported holding BHVN - Biohaven Pharmactl Hldg Co L - COM as of Q3 2017.
Biohaven Pharmactl Hldg Co L - COM (BHVN) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.7M shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, LLC (2M shares), Vivo Capital, LLC (1.98M shares), VHCP Management II, LLC (1.66M shares), BlackRock Inc. (1.14M shares), FMR LLC (1.04M shares), ALLIANCEBERNSTEIN L.P. (864K shares), WELLINGTON MANAGEMENT GROUP LLP (825K shares), Knoll Capital Management, LP (807K shares), JANUS HENDERSON GROUP PLC (689K shares), and JPMORGAN CHASE & CO (478K shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.